Eurofins-Cerep SA (ZEP2) Price & Analysis

0 Followers

ZEP2 Stock Chart & Stats

Currently, no data available

Please return soon. This page is being updated.

Eurofins-Cerep SA News

Eurofins Cerep Reports Revenue Decline Yet Expands Services

Eurofins-Cerep SA (FR:ALECR) has released an update. Eurofins Cerep SA reported a decrease in 2023 revenue by 7.47%...

2y ago

Eurofins-Cerep Experiences Decrease in Revenue

Eurofins-Cerep SA (FR:ALECR) has released an update. Eurofins-Cerep SA reported a decrease in revenue for the first semester...

2y ago

ZEP2 FAQ

What was Eurofins-Cerep SA’s price range in the past 12 months?

Currently, no data Available

What is Eurofins-Cerep SA’s market cap?

Eurofins-Cerep SA’s market cap is €82.23M.

When is Eurofins-Cerep SA’s upcoming earnings report date?

Eurofins-Cerep SA’s upcoming earnings report date is Sep 17, 2026 which is in 49 days.

How were Eurofins-Cerep SA’s earnings last quarter?

Currently, no data Available

Is Eurofins-Cerep SA overvalued?

According to Wall Street analysts Eurofins-Cerep SA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Eurofins-Cerep SA pay dividends?

Eurofins-Cerep SA does not currently pay dividends.

What is Eurofins-Cerep SA’s EPS estimate?

Eurofins-Cerep SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Eurofins-Cerep SA have?

Eurofins-Cerep SA has 5,045 shares outstanding.

What happened to Eurofins-Cerep SA’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Eurofins-Cerep SA?

Currently, no hedge funds are holding shares in DE:ZEP2

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Eurofins-Cerep SA

Established in 1989 and headquartered in Vienne, France, Eurofins Cerep SA delivers a broad spectrum of drug discovery support to pharmaceutical and biotechnology enterprises across the globe. The company's specialized offerings include the management of chemical compounds, high-throughput screening capabilities, in vitro safety assessments, optimization of lead compounds (SAR profiling), in vitro ADME evaluations, and in vivo pharmacokinetic (PK) studies. Furthermore, it provides expert services in assay development and design. The organization, originally known as Cerep SA, officially adopted the name Eurofins Cerep SA in June 2014.